Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lonardi

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Second-line chemotherapy in advanced biliary cancer: the present now will later be pastC Vivaldi, L Fornaro, S Cereda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2006
Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II studyU Basso, L Fratino, A Brunello, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2018
Cutaneous infiltration of plasmacytoid dendritic cells and T regulatory cells in skin lesions of polymorphic light eruptionM T Rossi, M Arisi, S Lonardi, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancerY Y Janjigian, E Smyth, L Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II studyA A Brandes, U Basso, F Vastola, et al.
European Journal of Neurology|September 5, 2012
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findingsC Briani, M Campagnolo, M Lucchetta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 29, 2006
Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancerE Urso, S Serpentini, S Pucciarelli, et al.
The Journal of Pathology|September 16, 2008
Identification of CXCL13 as a new marker for follicular dendritic cell sarcomaW Vermi, S Lonardi, D Bosisio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2005
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancerC Aschele, M L Friso, S Pucciarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracilC Aschele, D Debernardis, R Bandelloni, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Second-line chemotherapy in advanced biliary cancer: the present now will later be pastC Vivaldi, L Fornaro, S Cereda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2006
Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II studyU Basso, L Fratino, A Brunello, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2018
Cutaneous infiltration of plasmacytoid dendritic cells and T regulatory cells in skin lesions of polymorphic light eruptionM T Rossi, M Arisi, S Lonardi, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancerY Y Janjigian, E Smyth, L Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II studyA A Brandes, U Basso, F Vastola, et al.
European Journal of Neurology|September 5, 2012
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findingsC Briani, M Campagnolo, M Lucchetta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 29, 2006
Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancerE Urso, S Serpentini, S Pucciarelli, et al.
The Journal of Pathology|September 16, 2008
Identification of CXCL13 as a new marker for follicular dendritic cell sarcomaW Vermi, S Lonardi, D Bosisio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2005
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancerC Aschele, M L Friso, S Pucciarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracilC Aschele, D Debernardis, R Bandelloni, et al.
Pageof 12